Harold Brakewood
Vermogen: 63 758 $ op 31-05-2026
Vermogen: 63 758 $ op 31-05-2026
Harold E.
Brakewood is Chief Business Officer at Immuneering Corp.
since 2023.
From 2015 to 2021, served as Vice President & Head-Oncology Business Unit at Regeneron Pharmaceuticals, Inc. Education includes undergraduate degree from Bowdoin College, graduate degree from Dartmouth College, and MBA from Harvard Business School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-02-2026 | 11.050 ( 0,02% ) | 63 759 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNEERING CORPORATION | Corporate Officer/Principal | 28-03-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-12-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bowdoin College
Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau